Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery
Cholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers and approximately 3% of gastrointestinal tumors. While rare, the ...
Nov 29, 2022
0
25